Virologist Beata Halasi cured her stage III breast cancer using a self-developed therapy involving oncolytic viruses, marking a controversial foray into self-experimentation. After ten publishers rejected her study, Halasi detailed her journey in the journal ‘Vaccines,’ highlighting the effectiveness of her treatment which triggered an immune response against her tumor. Despite achieving remission, experts express ethical concerns about self-experimentation and the potential influence on others seeking unproven alternatives. As Halasi shifts her research focus to animal trials on viral therapies, the discourse on the implications of such personal methods continues.

Source